Global Pulmonary Function Testing Market Size, Share, Forecast Report, 2020-2027

Global Pulmonary Function Testing Market is expected to register 8.18% CAGR and is anticipated to reach USD 7,716.6 Million by 2023. Immunoassays are in-vitro tests that use antigen-antibody reaction to detect the concentrations of a wide range of biological substances in the blood and other fluids. Immunoassays are extensively used in several areas of pharmaceutical research such as therapeutic drug monitoring, disease diagnosis, clinical pharmacokinetic, and bioequivalence studies in drug discovery.
Increasing prevalence of respiratory diseases, growth in the elderly population, and the rising prevalence of lung cancer are the major drivers propelling market growth. However, stringent regulatory policies and the increasing cost of pulmonary devices may constrain the growth of the market.

Key Players

The prominent players in the global pulmonary function testing market are COSMED srl, Vyaire Medical, Inc, Schiller, Medical Equipment Europe GmbH, Medical Electronic Construction, ECO MEDICS AG, CHEST M.I., Inc, MGC Diagnostic Corporation, and Medical Technologies.

Intended Audience

Medical device manufacturers and distributors
Government research organizations
Hospitals and clinics
Regulatory agencies
Pharmaceutical companies
Some of the key strategies followed by the players operating in the global pulmonary function testing market were innovation, product development, acquisition, and expansion.

Segmentation

The global pulmonary function testing market has been segmented into type, test type, component, application, and end user.

By type, the global market has been divided into complete PFT systems and portable PFT systems. Based on test type, the global market has been segmented into spirometry, lung volume, gas exchange testing, maximal voluntary ventilation, oxygen titration test, and high-altitude simulation testing. By component, the global market has been segmented into software, hardware, and services. By application, the global market has been segmented into chronic obstructive pulmonary disease, asthma, chronic shortness of breath, restrictive lung disease. By end user, the global market has been bifurcated into hospital/clinical laboratories and diagnostic laboratories.

Global Pulmonary Function Testing Market, by Type

• Complete PFT Systems
• Portable PFT Systems

Global Pulmonary Function Testing Market, by Test Type

• Spirometry
• Lung Volume
• Gas Exchange Testing
• Maximal Voluntary Ventilation
• Oxygen Titration Test
• High Altitude Simulation Testing
• Others

Global Pulmonary Function Testing Market, by Component

• Software
• Hardware
• Services

Global Pulmonary Function Testing Market, by Application

• Chronic Obstructive Pulmonary Disease
• Asthma
• Chronic Shortness of Breath
• Restrictive Lung Disease

Global Pulmonary Function Testing Market, by End User

• Hospital/Clinical Laboratories
• Diagnostics Laboratories

Global Pulmonary Function Testing Market, by Region

• Americas
  • North America
    • US
    • Canada
  • Latin America

• Europe
  • Western Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Western Europe
  • Eastern Europe

• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific

• Middle East & Africa
  • Middle East
  • Africa

Available Additional Customizations

• Additional Companies
  • Schiller AG
  • MGC Diagnostics
  • Hocoma
  • Cosmed
  • Ganshorns